Check Out What Whales Are Doing With MRNA
Portfolio Pulse from Benzinga Insights
A whale investor has taken a bearish stance on Moderna (NASDAQ:MRNA), with 63% of the investors opening trades with bearish expectations. The total amount for puts is $353,442 and for calls is $96,920. Whales have been targeting a price range from $95.0 to $230.0 for Moderna over the last 3 months. Argus Research maintains their Buy rating on Moderna, with a price target of $140.
September 19, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
A whale investor has taken a bearish stance on Moderna. The total amount for puts is $353,442 and for calls is $96,920. Argus Research maintains their Buy rating on Moderna, with a price target of $140.
The bearish stance taken by a whale investor, along with the higher total amount for puts compared to calls, indicates a potential short-term downward pressure on Moderna's stock price. However, Argus Research's maintained Buy rating and $140 price target suggest a positive long-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100